Medical Device News Magazine

Light Deck

MBio is Seeking FDA Approval for LightDeck® Platform

MBio has been working with DARPA on a program, "Point-of-care Monitoring of the Host-Pathogen Interaction During Infection," since February 2018.
- Advertisement -spot_img

Latest News

RetiSpec Closes $10M USD to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer’s Disease

This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
- Advertisement -spot_img